Pathophysiological role of the cytokine network in the anterior pituitary gland

Frontiers in Neuroendocrinology

Volumn 20, Issue 1, 1999, Pages 71-95

  Arzt, Eduardo ^a   Pereda, Marcelo Páez ^b   Castro, Carolina Perez ^a   Pagotto, Uberto ^b   Renner, Ulrich ^b   Stalla, Günter K ^b  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Adenoma growth; Anterior pituitary; Autocrine paracrine; Cytokines

Indexed keywords

CORTICOTROPIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ANIMAL CELL; CELL COMMUNICATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GROWTH REGULATION; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0345003717     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1006/frne.1998.0176     Document Type: Article

References (178)

1. Adams E F, Newton C J, Tait G H, Braunsberg H, Reed M J, James V HT. Paracrine influence of human breast stromal fibroblasts on breast epithelial cells: Secretion of a polipeptide which stimulates reductive 17β oestradiol dehydrogenase activity. Int J Cancer. 42:1988;119-122.
2. Adams E F, Rafferty B, White M C. Interleukin-6 is secreted by breast fibroblasts and stimulates 17 β oestradiol oxidoreductase activity of MCF-7 cells: Possible paracrine regulation of breast 17 β oestradiol levels. Int J Cancer. 49:1991;118-121.
3. Akita S, Malkin J, Melmed S. Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion. Endocrinology. 137:1996;3140-3143.
4. Akita S, Webster J, Ren S G, Takino H, Said J, Zand O, Melmed S. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J Clin Invest. 95:1995;1288-1298.
5. Alexander J M, Biller B MK, Bikkal H, Zervas N T, Arnold A, Klibanski A. Clinically non-functioning pituitary tumors are monoclonal in origin. J Clin Invest. 86:1990;336-340.
6. Allaerts W, Carmeliet P, Denef C. New perspectives in the function of pituitary folliculo-stellate cells. Mol Cell Endocrinol. 71:1990;73-81.
7. Andersson L B, Björk L, Dinarello C A, Towbin H, Andersson U. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immunol. 22:1991;2617-2623.
8. Arend W P. Interleukin 1 receptor antagonist: A new member of the interleukin 1 family. J Clin Invest. 88:1991;1445-1451.
9. Arend W P, Smith M F, Janson R W, Joslin F G. IL-1 receptor antagonist and IL-1β production in human monocytes are regulated differently. J Immunol. 147:1991;1530-1536.
10. Arzt E, Buric R, Stelzer G, Stalla J, Sauer J, Renner U, Stalla G K. Interleukin involvement in anterior pituitary cell growth regulation: effects of interleukin-2 (IL-2) and IL-6. Endocrinology. 132:1993;459-467.
11. Arzt E, Sauer J, Buric R, Stalla J, Renner U, Stalla G K. Characterization of Interleukin-2 (IL-2) receptor expression and action of IL-2 and IL-6 on normal anterior pituitary cell growth. Endocrine. 3:1995;113-119.
12. Arzt E, Stelzer G, Renner U, Lange M, Müller O A, Stalla G K. Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures. J Clin Invest. 90:1992;1944-1951.
13. Baes M, Allaerts W, Denef C. Evidence for functional communication between folliculo-stellate cells and hormone secreting cells in perifused anterior pituitary cell aggregates. Endocrinology. 120:1987;685-691.
14. Bai X F, Zhu J, Zhang G X, Kaponides G, Hojeberg B, Van der Meide P H, Link H. IL-10 suppresses experimental autoimmune neuritis and down regulates Th1-type immune responses. Clin Immunol Immunopathol. 83:1997;117-126.
15. Ban E, Marquette C, Sarrieu A, Fitzpatrick F, Fillion G, Milon G, Rostene W, Haour H. Regulation of interleukin-1 receptor expression on mouse brain and pituitary by lipopolysaccharide and glucocorticoids. Neuroendocrinology. 58:1993;581-587.
16. Ban E, Miloan G A, Prudhomme N, Fillion G, Haour F. Receptors for IL-1 in mouse brain. Mapping and neuronal localization in hippocampus. Neuroscience. 43:1991;21-30.
17. Barbara J, Smith W B, Gamble J R, Van Ostade X, Vandenabeele P, Tavernier J, Fiers W, Vadas M A, Lopez A F. Dissociation of TNF-α citotoxic and proinflammatory activities by p55 receptor and p75 receptor-selective TNF-α mutants. EMBO J. 13:1994;843-850.
18. Bateman A, Singh A, Kral T, Solomon S. The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev. 10:1989;92-112.
19. Beach J E, Smallridge R C, Kinzer C A, Bernton E W, Holaday J W, Fein H G. Rapid release of multiple hormones from rat pituitaries perifused with recombinant interleukin-1. Life Sci. 44:1989;1-7.
20. Bernardini R, Kamilaris T C, Calogero A E, Johnson E O, Gomez M T, Gold P W, Chrousos G P. Interactions between tumor necrosis factor-α hypothalamic corticotroping-releasing hormone and adrenocorticotropin secretion in the rat. Endocrinology. 126:1990;2876-2881.
21. Bernhagen J, Calandra T, Mitchell R A, Martin S B, Tracey K J, Voelter W, Manogue K R, Cerami A, Bucala R. MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia. Nature. 365:1993;756-759.
22. Bernton E W, Beach J E, Holaday J W, Smallridge R C, Fein H G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science. 238:1987;519-521.
23. Besedovsky H O, del Rey A. Immune-neuroendocrine circuits: Integrative role of cytokines. Front Neuroendocrinol. 13:1992;61-94.
24. Besedovsky H O, del Rey A, Sorkin E. Lymphokine containing supernatans from con A-stimulated cells increase corticosterone blood levels. J Immunol. 126:1981;385-387.
25. Besedovsky H O, del Rey A, Sorkin E, Lotz W, Schwulera U. Lymphoid cells produce an immunoregulatory glucocorticoid increasing factor (GIF) acting through the pituitary gland. Clin Exp Immunol. 59:1985;622-628.
26. Besedovsky H O, del Rey A, Sorkin E CA, Dinarello C D. Immunoregulatory feedbak between interleukin-1 and glucocorticoids hormones. Science. 233:1986;652-654.
27. Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature. 320:1986;584-588.
28. Beutler B, Krochin N, Milsark I W, Leudke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 232:1986;977-980.
29. Beutler B, Milsark I W, Cerami A. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 229:1985;869-871.
30. Biller B MK, Alexander J M, Zervas N T, Hedley-Whyte E T, Arnold A, Klibanski A. Clonal origins of adrenocorticotropin- secreting pituitary tissue in Cushing's disease. J Clin Endocrinol Metab. 75:1992;1303-1309.
31. Boldin M P, Mett I L, Varfolomeev E E, Chumakov I, Shemer-Avni Y, Camonis J H, Wallach D. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J Biol Chem. 270:1995;387-391.
32. Bristulf J, Simoncsits A, Bartfai T. Characterization of a neuronal interleukin 1 receptor and the corresponding mRNA in the mouse anterior pituitary cell line AtT-20. Neurosci Lett. 128:1991;173-176.
33. Brown S L, Smith L R, Blalock J E. Interleukin 1 and Interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells. J Immunol. 139:1987;3181-3183.
34. Bubeník J, Lotzová E, Indrová M, Simová J, Jandlová T, Buveníková D. Use of IL-2 gene transfer in local immunotherapy of cancer. Cancer Lett. 62:1992;257-262.
35. Cambronero J C, Rivas F J, Borrel J, Gauza C. Interleukin-1-beta induces pituitary adrenocorticotropin secretion: Evidence for glucocorticoid modulation. Neuroendocrinology. 55:1992;648-654.
36. Carmeliet P, Vankelecom H, Van Damme J, Billiau A, Denef C. Release of interleukin-6 from anterior pituitary cell aggregates: Developmental pattern and modulation by glucocorticoids and forskolin. Neuroendocrinology. 53:1991;29-34.
37. Carter D A. Expression of leukemia inhibitory factor/cholinergic differentiation factor is linked to adrenoreceptor stimulation. Biochem Soc Trans. 23:1994;114S.
38. Chakravarty P K, Fuji H, Abu-hadid M M, Hsu S C, Sood A K. Tumorigenicity of interleukin 2-cDNA-transfected L1210 lymphoma and its in vivo variants is modulated by changes in IL-2 expression: Potential therapeutic implications. Cancer Immunol Immunother. 35:1992;347-354.
39. Cheifetz S, Ling N, Guillemin R, Massague J. A surface component on GH3 pituitary cells that recognizes transforming growth factor-β, activin and inhibin. J Biol Chem. 263:1988;17225-17228.
40. Clement M V, Stamenkovic I. Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions. J Exp Med. 180:1994;557-567.
41. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri J G, Dower S K, Sims J E, Mantovani A. Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4. Science. 261:1993;472-475.
42. Cornil I, Theodorescu D, Man S, Herlyn M, Jambrosic J, Kerbel R S. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA. 88:1991;6028-6032.
43. Costas M, Trapp T, Páez Pereda M, Sauer J, Rupprecht R, Nahmod V E, Reul J MHM, Holsboer F, Arzt E. Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. J Clin Invest. 98:1996;1409-1416.
44. Cunningham E T, Wada E, Carter D B, Tracey D E, Battery J F, De Souza E B. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J Neurosci. 3:1992;1101-1114.
45. Denicoff K D, Durkin T M, Lotze M T, Quinlan P E, Davis C L, Listwak S J, Rosenberg S A, Rubinow D R. The neuroendocrine effects of interleukin-2 treatment. J Clin Endocrinol Metab. 69:1989;402-410.
46. DeSouza E B, Webster E L, Grigoriadis D E, Tracey D E. Corticotropin-releasing factor (CRF) and interleukin-1 (IL-1) receptors in the brain-pituitary-immune axis. Psychopharmacol Bull. 25:1989;299-305.
47. Dinarello C A. Interleukin-1 and Interleukin-1 antagonism. Blood. 77:1991;1627-1652.
48. Dittel B N, Sant' Angelo D B, Janeway C AJ. Peptide antagonists inhibit proliferation and the production of IL-4 and/or IFN-gamma in T helper 1, T helper 2, and T helper 0 clones bearing the same TCR. J Immunol. 158:1997;4065-4073.
49. Eccles, S, Russel, S, Collins, M, Inhibition of Tumor Growth: Metastasis by IL-2 Secreting Rodent Sarcoma Cells, 4th Congress on Hormones and Cancer, Amsterdam, The Netherlands, 1991, 328.
50. Eisenberg S P, Evans R J, Arend W P, Verderber E, Brewer M T, Hannum C H, Thompson R C. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 343:1990;341-346.
51. Ezzat S, Melmed S. The role of growth factors in the pituitary. J Endocrinol Invest. 13:1990;691-698.
52. Fagarasan M O, Aiello F, Muegge K, Durum S, Axelrod J. Interleukin 1 induces β-endorphin secretion via Fos and Jun in AtT20 pituitary cells. Proc Natl Acad Sci USA. 87:1990;7871-7874.
53. Fagarasan M O, Bishop J F, Rinaudo M S, Axelrod J. Interleukin 1 induces early protein phosphorylation and requires only a short exposure for late induced secretion of β-endorphin in a mouse pituitary cell line. Proc Natl Acad Sci USA. 87:1990;2555-2559.
54. Fagarasan M O, Eskay R, Axelrod J. Interleukin 1 potentiates the secretion of β-endorphin secretion by secretagogues in a mouse pituitary cell line (AtT20). Proc Natl Acad Sci USA. 86:1989;2070-2073.
55. Farrar W L. Endorphin modulation of lymphokine activity. Opioid Peptides in the Periphery. 1984;Elsevier, Amsterdam. p. 159-165.
56. Ferrara N, Winer J, Henzel W J. Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: Identification as leukemia inhibitor factor. Proc Natl Acad Sci USA. 89:1992;698-702.
57. Florio T, Meucci E, Landolfi E, Grimaldi M, Ventra C, Scorziello A, Mariono A, Schettini G. Interleukin-1 modulation of anterior pituitary function: Effect on hormone release and second messenger systems. Pharmacol Res. 21:1989;21-36.
58. Fukata J, Usui T, Naitoh Y, Nakai Y, Imura H. Effects of recombinant human interleukin-1α, -1β, 2 and 6 on ACTH synthesis and release in the mouse pituitary tumor cell line AtT-20. J Endocrinol. 122:1989;33-39.
59. Gabellec M-M, Griffais R, Fillion G, Haour F. Expression of interleukin-1α, interleukin-1β and interleukin-1 receptor antagonist mRNA in mouse brain: Regulation by bacterial lipopolysaccharide (LPS) treatment. Brain Res Mol Brain Res. 31:1995;122-130.
60. Gaillard R C, Turnill D, Sappino P, Muller A F. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology. 127:1990;101-106.
61. Gatti S, Bartfai T. Induction of tumor necrosis factor-α mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res. 624:1993;291-294.
62. Gidlund M, Orn A, Wigzell H, Senik A, Gresser I. Enhanced NK cell activity in mice infected with interferon and interferon inducers. Nature. 273:1978;759-761.
63. Granowitz E V, Clark B D, Vannier E, Callahan M V, Dinarello C A. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Blood. 79:1992;2356-2363.
64. Green V L, Atkin L, Speirs V, Jeffreys R V, Landolt B, Mathew B, Hopkins L, White M C. Cytokine expression in human anterior pituitary adenomas. Clin Endocrinol. 45:1996;179-185.
65. Grimaldi M, Meucci O, Scorziello A, Florio T, Ventra C, De Mercato R, Schettini G. Interleukin 6 modulation of second messenger systems in anterior pituitary cells. Life Sci. 51:1992;1243-1248.
66. Gwosdow A R, Spencer J A, O'Connell N A, Abou-Samra A B. Interleukin-1 activates protein kinase A and stimulates adrenocorticotropin hormone release from AtT20 cells. Endocrinology. 132:1993;710-714.
67. Halper J, Parnell P G, Carter B J, Ren P, Scheithauer B W. Presence of growth factors in human pituitary. Lab Invest. 66:1992;639-645.
68. Haour G H, Ban E M, Milon G M, Baran D, Fillion G M. Brain Interleukin-1 receptors: Characterization and modulation after lipopolysaccharide injection. Prog Neuroendocrimmunol. 3:1990;196-204.
69. Harbuz M S, Stephanou A, Knight R A, Chover-Gonzalez A J, Lightman S L. Action of interleukin-2 and interleukin-4 on CRF mRNA in the hypothalamus and POMC mRNA in the anterior pituitary. Brain Behav Immun. 6:1992;214-222.
70. Harbuz M S, Stephanou A, Sarlis N, Lightman S L. The effects of recombinant human interleukin (IL)-1α, IL-1β or IL-6 on hypothalamo-pituitary-adrenal axis activation. J Endocrinol. 133:1992;349-355.
71. Harel G, Shamoun D S, Kane J P, Magner J A, Szabo M. Prolonged effects of tumor necrosis factor-α on anterior pituitary hormone release. Peptides. 16:1995;641-645.
72. Hashimoto K, Nishioka T, Tojo C, Takao T. Nitric oxide plays no role in ACTH release induced by interleukin-β, corticotropin-releasing hormone, arginine vasopressin and phorbol myristate acetate in rat pituitary cell cultures. Endocr J. 42:1995;435-439.
73. Hermus A RMM, Sweep C GJ. Cytokines and the hypothalamic-pituitary-adrenal axis. J Steroid Biochem Mol Biol. 37:1990;867-871.
74. Hilkens C M, Vermeulen H, Van Neerven R J, Snijdewint F G, Wierenga E A, Kapsenberg M L. Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. J Immunol. 25:1995;59-63.
75. Johnson H M, Farrar W L. The role of γ-interferon like lymphokine in the activation of T cells for expression of interleukin 2 receptors. Cell Immunol. 75:1983;154-159.
76. Jones T H, Daniels M, James R A, Justice S K, McCorkle R, Price A, Kendall-Taylor P, Weetman A P. Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas. J Clin Endocrinol Metab. 78:1994;180-187.
77. Jones T H, Justice S, Price A, Chapman K. Interleukin-6 secreting human pituitary adenomas in vitro. J Clin Endocrinol Metab. 73:1991;207-209.
78. Jones T H, Justice S K. Effect of interleukin-6 on human pituitary tumor cell growth. J Endocrinol. 144:1995;P292.
79. Jones T H, Kennedy R L, Justice S K, Price A. Interleukin-1 stimulates the release of interleukin-6 from cultured human pituitary adenoma cells. Acta Endocrinol. 128:1993;405-410.
80. Karanth S, McCann S M. Anterior pituitary hormone control by interleukin-2. Proc Natl Acad Sci USA. 88:1991;2961-2965.
81. Karanth S, McCann S M. Influence of dopamine on the altered release of prolactin, luteinizing hormone and follicle stimulating hormone induced by interleukin-2 in vitro. Neuroendocrinology. 56:1992;871-880.
82. Keher P, Turnill D, Dayer J M, Muller A F, Gaillard R C. Human recombinant interleukin-1-beta and alpha, but not recombinant tumor necrosis alpha stimulate ACTH release from rat anterior pituitary cells in vitro in a prostaglandin E2 cAMP independent manner. Neuroendocrinology. 48:1988;160-166.
83. Kishimoto T, Taga T, Akira S. Cytokines signal transduction. Cell. 76:1994;253-262.
84. Kobayashi H, Fukata J, Murakami N, Usui T, Ebisui O, Muro S, Hanaoka I, Inove K, Imura H, Nakao K. Tumor necrosis factor receptors in the pituitary cells. Brain Res. 758:1997;45-50.
85. Koenig J I, Snow K, Clark B D, Toni R, Cannon J G, Shaw A R, Dinarello C A, Reichlin S, Lee S L, Lechan R M. Intrinsic pituitary interleukin 1-β is induced by bacterial lipopolysaccharide. Endocrinology. 126:1990;3053-3058.
86. Koff W C, Dunegan M A. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J Immunol. 135:1985;350-354.
87. Koike K, Hirota K, Ohmichi M, Kadowaki K, Ikegami H, Yamaguchi M, Miyake A, Tanizawa O. Tumor necrosis factor-α increases release of arachidonate and prolactin from rat anterior pituitary cells. Endocrinology. 128:1991;2791-2798.
88. Koike K, Masumoto N, Kasahara K, Yamaguchi M, Tasaka K, Hirota K, Miyake A, Tanizawa O. Tumor necrosis factor-α stimulates prolactin release from anterior pituitary cells: A possible involvement of intracellular calcium mobilization. Endocrinology. 128:1991;2785-2790.
89. Koyama C, Matsumoto H, Sakai T, Wakabayashi K, Ito A, Couch E F, Inoue K. Pituitary follicuo-stellate-like cells stimulate somatotropic pituitary tumor growth in nude mice. Endocr Pathol. 6:1995;67-75.
90. Kunert-Radek J, Radek A, Stepien H. Interleukin-2 stimulates cell proliferation of the growth hormone producing human pituitary adenoma in vitro. Biomed Lett. 49:1994;259-264.
91. Leonard W J, Depper J M, Crabtree G R, Rudikoff S, Pumphrey J, Robb R J, Krönke M, Svetlik P B, Peffer N J, Waldmann T A, Greene W C. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature. 311:1984;626-631.
92. Lotze M T, Frana L W, Sharrow S O, Robb R J, Rosenberg S A. In vivo administration of purified human interleukin 2. J Immunol. 134:1985;157-166.
93. Lu C, Kerbel R S. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol. 120:1993;1281.
94. Lu C, Vickers M, Kerbel R S. Interleukin-6: a fibroblast derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc Natl Acad Sci USA. 89:1992;9215-9219.
95. Lumpkin M D. The regulation of ACTH secretion by IL-1. Science. 238:1987;452-454.
96. Lyson K, McCann S M. The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology. 54:1991;262-266.
97. Maas R A, Van Weering H J, Dullens H FJ, Den Otter W. Intratumoral low-dose interleukin-2 induces rejection of distant solid tumor. Cancer Immunol Immunother. 33:1991;389-394.
98. Malarkey W B, Zvara B J. Interleukin-1β and other cytokines stimulate adrenocorticotropin release from cultured pituitary cells of patients with Cushing's disease. J Clin Endocrinol. 69:1989;196-199.
99. Marquette C, Van Dam A-M, Ban E, Lanièce P, Crumeyrolle-Arias M, Fillion G, Berkenbosh F, Haour F. Rat interleukin-1β binding sites in rat hypothalamus and pituitary gland. Neuroendocrinology. 62:1995;362-369.
100. Mastorakos G, Chrousos G P, Weber J S. Recombinat interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol. 77:1993;1690-1694.
101. Mastorakos G, Weber J S, Magiakou M A, Gunn H, Chrousos G P. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: Potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metabol. 79:1994;934-939.
102. Matsumoto H CK, Sawada T, Koike K, Hirota K, Miyake A, Arimura A, Inoue K. Pituitary folliculo-stellate-like cell line (TtT/GF) responds to novel hypophysiotrophic peptide (pituitary adenylate cyclase-activating peptide), showing increased adenosine 3′, 5′-monophosphate and interleukin-6 secretion and cell proliferation. Endocrinology. 133:1993;2150-2155.
103. Matta S G, Linner K M, Sharp B M. Interleukin-1α and interleukin-1β stimulate adrenocorticotropin secretion in the rat through a similar hypothalamic receptor(s): Effects of interleukin 1 receptor antagonist protein. Neuroendocrinology. 57:1993;14-22.
104. McMahan C J, Slack J L, Mosley B, Cosman D, Lupton S D, Brunton L L, Grubin C E, Wignall J M, Jenkins N A, Brannan C I, Copeland N G, Huebner K, Croce C M, Cannizzarro L A, Benjamin D, Dower S K, Spriggs S K, Sims J E. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10:1991;2821-2832.
105. Milenkovikc L, Rettori V, Snyder G D, Beutler B, McCann S M. Cachectin alters anterior pituitary release by a direct action in vitro. Proc Natl Acad Sci USA. 86:1989;2418-2422.
106. Mullen C A, Coale M M, Levy A T, Stetler-Stevenson W, Liotta L A, Brandt S, Blaese R M. Fibrosarcoma cells transduced with the IL-6 gene exhibit reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential. Cancer Res. 52:1992;6020-6024.
107. Murata T, Ying S-Y. Transforming growth factors and activin inhibit basal secretion of prolactin in a pituitary monolayer system. Proc Soc Exp Biol Med. 198:1991;599-605.
108. Nagata S, Golstein P. The Fas death factor. Science. 267:1995;1449-1455.
109. Naito Y, Fukata J, Tominaga T, Masui Y, Hirai Y, Murakami N, Tamai S, Mori K, Imura H. Adrenocorticotropic hormone-releasing activities of interleukins in a homologous in vivo system. Biochem Biophys Res Commun. 164:1989;1262-1267.
110. Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely moving rats. Biochem Biophys Res Commun. 155:1988;1459.
111. Nash A D, Brandon M R, Bello P A. Effects of tumor necrosis factor-α on growth hormone and interleukin 6 mRNA in ovine pituitary cells. Mol Cell Endocrinol. 84:1992;R31-R37.
112. Neta R, Perlstein R, Vogel S N, Ledney G D, Abrams J. Role of Interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor. J Exp Med. 175:1992;689-694.
113. Newton C J, Arzt E, Stalla G K. Involvement of the estrogen receptor in the growth response of pituitary cells to interleukin-2. Biochem Biophys Res Commun. 205:1994;1930-1937.
114. Ohmichi M, Hirota K, Koike K, Kurachi H, Ohtsuka S, Matsuzaki N, Yamaguchi M, Miyake A, Tanizawa O. Binding sites for interleukin-6 in the anterior pituitary gland. Neuroendocrinology. 55:1992;199-203.
115. Okusawa S, Gelfand J A, Ikejima T, Connolly R J, Dinarello C A. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest. 81:1988;1162-1172.
116. Oppenheim J J, Kovacs E J, Matsushima K, Durum S K. There is more than one interleukin 1. Immunol Today. 7:1986;45-56.
117. Oriss T B, McCarthy S A, Morel B F, Campana M A, Morel P A. Crossregulation between T helper cell (Th) 1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1. J Immunol. 158:1997;3666-3672.
118. Páez Pereda M, Goldberg V, Chervín A, Carrizo G, Molina A, Andrada J, Sauer J, Renner U, Stalla G K, Arzt E. Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants. Mol Cell Endocrinol. 124:1996;33-42.
119. Parnet P, Brunke D L, Goujon E, Mainard J D, Biragyn A, Arkins S, Dantzer R, Kelley K W. Molecular identification of two types of interleukin-1 receptors in the murine pituitary gland. J Neuroendocrinol. 5:1993;213-219.
120. Parsadaniantz S M, Lenoir V, Terlain B, Kerdelhue B. Lack of effect of interleukin-1α and -β, during in vitro perfusion, on anterior pituitary release of adrenocorticotropin hormone and β-endorphin in the male rat. J Neurosci Res. 34:1993;315-323.
121. Payne L C, Weigent D A, Blalock J E. Induction of pituitary sensitivity to interleukin-1: A new function for corticotropin-releasing hormone. Biochem Biophys Res Commun. 198:1994;480-484.
122. Perez F M, Rose J C, Schwartz J. Anterior pituitary cells: getting to know their neighbors. Mol Cell Endocrinol. 111:1995;C1-C6.
123. Perlstein R S, Mougey E H, Jackson W E, Neta R. Interleukin-1 and Interleukin-6 act synergistically to stimulate the release of adrenocorticotropic hormone in vivo. Lymphokine Cytokine Res. 10:1991;141-146.
124. Petitto J M, Huang Z, Rinker C M, McCarthy D B. Isolation of IL-2 receptor-β cDNA clones from AtT-20 pituitary cells: Constitutive expression and role in signal transduction. Neuropsychopharmacology. 17:1997;57-66.
125. Poutsiaka D D, Clark B D, Vannier E, Dinarello C A. Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated. Blood. 78:1991;1275-1281.
126. Ramierz F, Fowell D J, Puklavec M, Simmonds S, Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+T cells in vitro. J Immunol. 156:1996;2406-2412.
127. 4. Endocrinology. 128:1991;1981-1990.
128. Ray D W, Ren S G, Melmed S. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line: Role of STAT pathway. J Clin Invest. 97:1996;1852-1859.
129. Ren P, Scheithauer B W, Halper J. Immunohistological localization of TGF alpha, EGF, IGF-I and TGF beta in the normal human pituitary gland. Endocr Pathol. 5:1994;40-48.
130. Renner U, Gloddek J, Arzt E, Inoue K, Stalla G K. Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells. Exp Clin Endocrinol Diabetes. 105:1997;345-352.
131. Renner U, Newton C J, Pagotto U, Sauer J, Arzt E, Stalla G K. Involvement of interleukin-1 and interleukin-1 receptor antagonist in rat pituitary cell growth regulation. Endocrinology. 136:1995;3186-3193.
132. Renner U, Pagotto U, Arzt E, Stalla G K. Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review. Eur J Endocrinol. 135:1996;515-532.
133. Roberts A B, Sporn M B. Physiological actions and clinical applications of transforming growth factor-β Growth Factors. 8:1993;1-9.
134. Sauer J, Arzt E, Hopfner U, Gumprecht H, Stalla G K. Expression of interleukin-1 receptor antagonist in human pituitary adenomas in vitro. J Clin Endocrinol Metab. 79:1994;1857-1863.
135. Sawada T, Koike K, Kanda Y, Ikegami H, Jikihara T, Maeda T, Osako Y, Hirota K, Miyake A. Interleukin-6 stimulates cell proliferation of rat anterior pituitary clonal cell lines in vitro. J Endocrinol Invest. 18:1995;83-90.
136. Schneider, J, H, Hofman, F, M, Weiss, M, H, Hinton, D, R, Cytokine Expression in Pituitary Adenomas, 1993.
137. Schöbitz B, Van En Dobbelsteen M, Holsboer F, Sutanto W, De Kloet E R. Regulation of interleukin 6 gene expression in rat. Endocrinology. 132:1993;1569-1576.
138. 1. Cancer Res. 48:1988;6999-7003.
139. Sharp B M, Matta S G, Peterson P K, Newton R, Chao C, McAllen K. Tumor necrosis factor alpha is a potent ACTH secretagogue. Endocrinology. 124:1989;3131-3133.
140. Smith L R, Brown S L, Blalock J E. Interleukin-2 induction of ACTH secretion: Presence of an interleukin-2 receptor alpha-chain-like molecule on pituitary cells. J Neuroimmunol. 21:1989;249-254.
141. Spangelo B L, Isakson P C, MacLeod R M. Production of interleukin-6 by anterior pituitary cells is stimulated by increased intracellular adenosine 3′,5′-monophosphate and vasoactive intestinal peptide. Endocrinology. 127:1990;403-409.
142. Spangelo B L, Jarvis W D, Judd A M, MacLeod R M. Induction of interleukin-6 release by interleukin-1 in rat anterior pituitary cells in vitro: Evidence for an eicosanoid-dependent mechanism. Endocrinology. 129:1991;575-577.
143. Spangelo B L, Judd A M, Isakson P C, MacLeod R M. Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology. 127:1989;575-577.
144. Spangelo B L, Judd A M, Isakson P C, MacLeod R M. Interleukin-1 stimulates interleukin-6 release from rat anterior pituitary cells in vitro. Endocrinology. 128:1991;2685-2692.
145. Spangelo B L, Judd A M, MacLeod R M, Goodman D W, Isakson P C. Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami. Endocrinology. 127:1990;1779-1785.
146. Spangelo B L, MacLeod R M, Isakson P C. Production of interleukin-6 by anterior pituitary cells in vitro. Endocrinology. 126:1990;582-586.
147. Spangelo B L, Gorospe W C. Role of the cytokines in the neuroendocrine-immune system axis. Front Neuroendocrinol. 16:1995;1-22.
148. Späth-Schwalbe E, Born J, Schrezenmeier H, Bornstein S R, Stromeyer P, Drechsler S, Fehm H L, Porzsolt F. Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man. J Clin Endocrinol Metab. 79:1994;1212-1214.
149. Stefana B, Ray D W, Melmed S. Leukemia inhibitory factor (LIF) induces differentation of pituitary corticotroph function: A neuro-endocrine phenotypic swith. Proc Natl Acad Sci USA. 93:1996;12502-1206.
150. Sweep C GJ, Van der Meer M JM, Hermus A RMM, Smals A GH, Van der Meer J WM, Pesman G J, Willemsen S J, Benraad T J, Kloppenborg P WC. Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1β infusion: In vivo and in vitro studies. Endocrinology. 130:1992;1153-1164.
151. Takao T, Culp S G, De Souza E B. Reciprocal modulation of interleukin-1β (IL-1β) and IL-1 receptors by lypopolysacharide (endotoxin) treatment in the mouse brain-endocrine-immune axis. Endocrinology. 132:1993;1497-1504.
152. Takao T, Culp S G, Newton R C, De Souza E B. Type I interleukin-1 receptors in the mouse brain-endocrine-immune axis labeled with (125I) recombinant human interleukin-1 receptor antagonist. J Neuroimmunol. 41:1992;51-60.
153. Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Munakata H, Nakamura M, Sugamura K. Cloning of the γ chain of the human IL-2 receptor. Science. 257:1992;379-382.
154. Tartaglia L A, Ayres T M, Wong G HW, Goeddel D V. A novel domain within the 55 kD TNF receptor signals cell death. Cell. 74:1993;845-853.
155. Tatsuno I, Somogyvari-Vigh A, Mizumo K, Gottschall P E, Hidaka H, Arimura A. Neuropeptide regulation of interleukin-6 production from the pituitary: Stimulation by pituitary adenylate cyclase activating plypeptide and calcitonin gene-related peptide. Endocrinology. 129:1991;1797-1804.
156. Todd V L, Atkin S L, Speirs V, White M C. PCR expression of cytokines in anterior pituitary adenomas. J Endocrinol. 144:1995;P285.
157. Tominaga T, Fukata J, Fujimoto T, Ogawa K, Diamanstein T, Imura H, Nakao K. Immunocytochemical evidence for interleukin-2 receptor regulation on rat anterior pituitary and adrenals cells. Acta Histochem Cytochem. 29:1996;255-260.
158. Tracey K J, Beutler B, Lowry S F, Merryweather J, Wolpe S, Milsark I W, Hariri R J, Fahey T J III, Zentella A, Albert J D, Shires G T, Cerami A. Shock and tissue injury induced by recombinant human cachectin. Science. 234:1986;470-474.
159. Tsagarakis S, Kontogeorgeos G, Giannou P, Thalassinos N, Woollley J, Besser G M, Grossman A. Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: An immuno-cytochemical study. Clin Endocrinol. 37:1992;163-167.
160. Turnbull A V, Pitossi F J, Lebrun J J, Lee S, Meltzer J C, Nance D M, del Rey A, Besedovsky H O, Rivier C. Inhibition of tumor necrosis factor-α action within the CNS markedly local inflamation in rats. J Neurosci. 17:1997;3262-3273.
161. Turner M, Chantry M D, Katsikis P, Berger A, Brennan F M, Feldmann M. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β Eur J Immunol. 21:1991;1635-1639.
162. Uehara A, Gillis S, Arimura A. Effects of interleukin-1 on hormone release from normal rat pituitary cells in primary culture. Neuroendocrinology. 45:1987;343-347.
163. Van Zee K J, Stackpole S A, Montegut W J, Rogy M A, Calvano S E, Hsu K C, Chao M, Meschter C L, Loetscher H, Stüber D, Ettlin U, Wipf B, Lesslauer W, Lowry S F, Moldawer L L. A human tumor necrosis factor (TNF) α mutant that
164. Vankelecom H, Carmeliet P, Van Damme J, Billiau A, Denef C. Production of Interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology. 49:1989;102-106.
165. Vankelecom H, Matthys P, Van Damme J, Heremans H, Billiau A, Denef C. Immunocytochemical evidence that S-100 positive cells of the mouse anterior pituitary contain interleukin-6 immunoreactivity. J Histochem Cytochem. 41:1993;151-156.
166. Vankelekom H, Andries M, Billiau A, Denef C. Evidence that folliculo-stellate cells mediate the inhibitory effect of interferon-gamma on hormone secretion in rat anterior pituitary cell cultures. Endocrinology. 130:1992;3537-3546.
167. Vankelekom H, Carmeliet P, Heremans H, Van Damme J, Dijkmans R, Billiau A, Denef C. Interferon-γ inhibits stimulated adrenocorticotropin, prolactin and growth hormone secreton in normal rat anterior pituitary cell cultures. Endocrinology. 126:1990;2919-2926.
168. Velkeniers B, D'Hanes G, Smets G, Vergani P, Vanhaelst L, Hooghe-Peters E L. Expression of IL-6 mRNA in corticotroph cell adenomas. J Endocrinol Invest. 14: 1991;31.
169. Velkeniers B, Vergani P, Trouillas J, D'Haens J, Hooghe R J, Hooghe-Peters E L. Expression of IL-6 mRNA in normal rat and human pituitaries and in human pituitary adenomas. J Histochem Cytochem. 42:1994;67-76.
170. Wang Z, Ren S G, Melmed S. Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: A novel endotoxin-inducible neuro-endocrine interface. Endocrinology. 137:1996;2947-2953.
171. Webster E L, Tracey D E, De Souza E B. Upregulation of IL-1 receptors in mouse AtT20 pituitary tumors cells following treatment with corticotropin-releasing factor. Endocrinology. 129:1991;2796-2798.
172. Webster J, Ren S G, Melmed S. Leukemia inhibitory factor and oncostatin M stimulate ACTH secretion and POMC expression in mouse corticotroph tumor cells. J Endocrinol. 144:1995;294.
173. Woloski B MRNJ, Smith E M, Meyer W J, Fuller G M, Blalock J E. Corticotropin-releasing activity of monokines. Science. 230:1985;1035-1037.
174. Yamaguchi M, Koike K, Matsuzaki N, Yoshimoto Y, Taniguchi T, Miyake A, Tanizawa O. The interferon family stimulates the secretions of prolactin and interleukin-6 by the pituitary gland in vitro. J Endocrinol Invest. 14:1991;457-461.
175. Yamaguchi M, Matsuzaki N, Hirota K, Miyake A, Tanizawa O. Interleukin 6 possibly induced by interleukin 1 β in the pituitary gland stimulates the release of gonadotropins and prolactin. Acta Endocrinol. 122:1990;201-205.
176. Ying S Y, Becker A, Baird A, Ling N, Ueno N, Esch F, Guillemin R. Type beta transforming growth factor (TGF-β) is a potent stimulator of the basal secretion of follicle stimulating hormone (FSH) in a pituitary monolayer system. Biochem Biophys Res Commun. 135:1986;950-956.
177. Young H A. Regulation of interferon-gamma gene expression. J Interferon Cytokine Res. 16:1996;563-568.
178. Zakarian S, Eleazar M S, Silvers W S. Regulation of pro-opiomelanocortin biosynthesis and processing by transplantation immunity. Nature. 339:1989;553-556.